Compartmentalized drug localization studies in extracellular vesicles for anticancer therapy

Area of Science:

• Biotechnology
• Nanomedicine
• Drug Delivery

Background:

• Therapeutic extracellular vesicles (EVs) face challenges with low drug encapsulation efficiency compared to synthetic nanomedicines.
• EV membrane structure and drug physicochemical properties limit loading capacity.

Purpose of the Study:

• To demonstrate drug compartmentalization as a key parameter influencing the therapeutic potential of drug-loaded EVs.
• To compare the loading efficiency and therapeutic efficacy of free doxorubicin (DOX) versus lipid-conjugated doxorubicin (L-DOX) within human adipose mesenchymal stem cell (hADSC)-derived EVs.

Main Methods:

• Comparative drug loading analysis of free DOX and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) lipid-conjugated DOX (L-DOX) in hADSC EVs.
• Nano surface energy transfer (NSET), molecular simulation, and cryo-transmission electron microscopy (cryo-TEM) for compartmentalization analysis.
• Cellular investigations to assess internalization and therapeutic efficacy.

Main Results:

• Differential compartmentalization observed: L-DOX preferentially adsorbed to the EV surface, while free DOX was core-encapsulated.
• L-DOX loaded EVs (LDOX@EV) showed nearly three-fold higher drug content than free DOX loaded EVs (DOX@EV).
• LDOX@EV exhibited enhanced cellular internalization and therapeutic potential compared to DOX@EV and free L-DOX.

Conclusions:

• Drug compartmentalization within EVs is crucial for optimizing intracellular delivery, loading efficiency, and therapeutic effects.
• Surface compartmentalization of lipophilic drugs like L-DOX in EVs offers a promising strategy to enhance therapeutic outcomes.
• This study provides a foundation for developing advanced EV-based biotherapeutic delivery platforms for personalized medicine.